RJA
PETS icon

Raymond James & Associates’s PetMed Express PETS Stock Holding History

Raymond James & Associates’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,647
Closed -$312K – 4021
2022
Q4 		$312K Sell
17,647
-6,610
-27% -$131K ﹤0.01% 3190
2022
Q3 		$473K Sell
24,257
-5,443
-18% -$116K ﹤0.01% 2900
2022
Q2 		$591K Buy
29,700
+13,317
+81% +$298K ﹤0.01% 2811
2022
Q1 		$423K Sell
16,383
-2,244
-12% -$58.2K ﹤0.01% 3167
2021
Q4 		$471K Buy
18,627
+1,112
+6% +$30.8K ﹤0.01% 3124
2021
Q3 		$471K Sell
17,515
-7,873
-31% -$227K ﹤0.01% 3109
2021
Q2 		$809K Buy
25,388
+10,047
+65% +$319K ﹤0.01% 2731
2021
Q1 		$540K Sell
15,341
-18,149
-54% -$631K ﹤0.01% 2964
2020
Q4 		$1.07M Buy
33,490
+21,674
+183% +$668K ﹤0.01% 2296
2020
Q3 		$374K Sell
11,816
-19,204
-62% -$636K ﹤0.01% 2820
2020
Q2 		$1.11M Buy
31,020
+23,927
+337% +$831K ﹤0.01% 2093
2020
Q1 		$204K Buy
+7,093
New +$186K ﹤0.01% 3031
2019
Q3 		– Sell
-55,847
Closed -$875K – 3694
2019
Q2 		$875K Buy
55,847
+23,041
+70% +$453K ﹤0.01% 2296
2019
Q1 		$747K Buy
32,806
+9,894
+43% +$223K ﹤0.01% 2382
2018
Q4 		$533K Sell
22,912
-4,517
-16% -$121K ﹤0.01% 2515
2018
Q3 		$906K Buy
27,429
+5,036
+22% +$188K ﹤0.01% 2312
2018
Q2 		$987K Sell
22,393
-9,531
-30% -$369K ﹤0.01% 2224
2018
Q1 		$1.33M Buy
31,924
+12,262
+62% +$566K ﹤0.01% 1941
2017
Q4 		$895K Buy
+19,662
New +$775K ﹤0.01% 2188
2016
Q2 		– Sell
-12,000
Closed -$215K – 3082
2016
Q1 		$215K Buy
+12,000
New +$206K ﹤0.01% 2533
2015
Q2 		– Sell
-16,135
Closed -$267K – 2428
2015
Q1 		$267K Buy
16,135
+198
+1% +$3.07K ﹤0.01% 2248
2014
Q4 		$229K Sell
15,937
-1,400
-8% -$18.9K ﹤0.01% 2188
2014
Q3 		$236K Buy
17,337
+208
+1% +$2.9K ﹤0.01% 2117
2014
Q2 		$231K Buy
+17,129
New +$226K ﹤0.01% 2125
2013
Q4 		– Sell
-27,921
Closed -$455K – 2007
2013
Q3 		$455K Buy
+27,921
New +$436K ﹤0.01% 1635

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James & Associates's PETS Position: Q1 2023 in Review

Raymond James & Associates sold out of PetMed Express (PETS) in Q1 2023, closing a stake of 17,647 shares — an estimated $312K sold.

Raymond James & Associates first reported a position in PETS in Q3 2013 and held it in 25 quarters. The position peaked at $1.33M in Q1 2018. 165 funds tracked by Wall St. Rank hold PETS as of Q1 2023.

  • Raymond James & Associates reported no remaining PetMed Express position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 17,647 PetMed Express shares in Q1 2023, an estimated $312K.
  • Raymond James & Associates first reported a position in PetMed Express in Q3 2013 and held it in 25 quarters.
  • Raymond James & Associates's PetMed Express position peaked at $1.33M in Q1 2018.
  • 165 funds tracked by Wall St. Rank held PetMed Express as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.